#614104
Table of Contents
A number sign (#) is used with this entry because of evidence that autosomal dominant intellectual developmental disorder-7 (MRD7) is caused by heterozygous disruption of the DYRK1A gene (600855) on chromosome 21q22.
Van Bon et al. (2011) reported a woman with primary microcephaly (-3 SD), severe mental retardation without speech, anxious autistic behavior, and dysmorphic features, including bitemporal narrowing, deep-set eyes, large simple ears, and a pointed nasal tip. As an infant, she had failure to thrive, abnormal movements, hypoactivity, and febrile seizures. Brain MRI at age 25 showed a mildly atrophic brain without structural abnormalities. Other features included eczema, hypoplasia of breasts, hallux valgus of feet, and an irregular implant of the toes. Van Bon et al. (2011) noted that their patient clearly resembled the 2 patients reported by Moller et al. (2008).
Courcet et al. (2012) reported a 14-year-old girl with severe mental retardation, primary microcephaly (-6 SD), and facial dysmorphic features, including thick lower lip, mild hypotelorism, and hypoplastic earlobes. She had a history of intrauterine growth retardation and feeding difficulties, and developed seizures of multiple types at age 18 months. Other features included severe speech delay, diffuse cortical atrophy on MRI, and hand stereotypies.
Moller et al. (2008) reported 2 unrelated patients with microcephaly, intrauterine growth retardation, postnatal feeding difficulties, and dysmorphic facial features who each had a de novo balanced translocation disrupting the DYRK1A gene: t(9;21)(p12;q22) and t(2;21)(q22;q22), respectively. In the second patient, the 2q22 breakpoint was within intron 39 of the LRP1B (608766) gene. The first child, 24 months old at the time of the report, had large low-set ears, long philtrum, micrognathia, hypogenesis of the corpus callosum, mild developmental delay, and febrile seizures. The second child, age 10 years, had large ears, flat philtrum, asymmetric head, febrile seizures, severe mental retardation, no speech development, and a small ventricular septal defect. Moller et al. (2008) noted the phenotypic similarities to patients with partial monosomy 21 (Matsumoto et al., 1997) and suggested that haploinsufficiency of the DYRK1A gene results in microcephaly as well as other neurodevelopmental anomalies.
In a woman with mental retardation, microcephaly, and dysmorphic features, van Bon et al. (2011) identified a de novo heterozygous deletion in the DYRK1A gene (600855.0001). This patient was identified among a larger group of 3,009 mentally retarded individuals studied for copy number variations in the DYRK1A gene. The report supported a role for DYRK1A in human brain development and showed that haploinsufficiency of DYRK1A can cause a distinctive clinical syndrome with mental retardation, primary microcephaly, intrauterine growth retardation, facial dysmorphism, impaired motor functioning, and behavioral problems.
O'Roak et al. (2012) identified 3 de novo mutations in DYRK1A, 2 frameshift mutations and 1 splice site mutation (600855.0002-600855.0004), among 44 candidate gene sequences in 2,446 autism spectrum disorder probands. The 3 patients with DYRK1A mutations had microcephaly relative to individuals screened without DYRK1A mutations (2-sample permutation test, 2-sided p = 0.0005), and the head sizes of these patients was smaller than those of their parents.
In a 14-year-old girl with severe mental retardation, growth retardation, microcephaly, speech delay, and seizures, Courcet et al. (2012) identified a de novo heterozygous truncating mutation in the DYRK1A gene (600855.0005). This patient was ascertained from a larger cohort of 150 patients with a similar phenotype; she was the only one who had a mutation in the DYRK1A gene.
Courcet, J.-B., Faivre, L., Malzac, P., Masurel-Paulet, A., Lopez, E., Callier, P., Lambert, L., Lemesle, M., Thevenon, J., Gigot, N., Duplomb, L., Ragon, C., Marle, N., Mosca-Boidron, A. L., Huet, F., Philippe, C., Moncla, A., Thauvin-Robinet, C. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy. J. Med. Genet. 49: 731-736, 2012. [PubMed: 23099646, related citations] [Full Text]
Matsumoto, N., Ohashi, H., Tsukahara, M., Kim, K. C., Soeda, E., Niikawa, N. Possible narrowed assignment of the loci of monosomy 21-associated microcephaly and intrauterine growth retardation to a 1.2-Mb segment at 21q22.2. (Letter) Am. J. Hum. Genet. 60: 997-999, 1997. [PubMed: 9106547, related citations]
Moller, R. S., Kubart, S., Hoeltzenbein, M., Heye, B., Vogel, I., Hansen, C. P., Menzel, C., Ullmann, R., Tommerup, N., Ropers, H.-H., Tumer, Z., Kalscheuer, V. M. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am. J. Hum. Genet. 82: 1165-1170, 2008. [PubMed: 18405873, images, related citations] [Full Text]
O'Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., Munson, J., Hiatt, J. B., and 14 others. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338: 1619-1622, 2012. [PubMed: 23160955, images, related citations] [Full Text]
van Bon, B. W. M., Hoischen, A., Hehir-Kwa, J., de Brouwer, A. P. M., Ruivenkamp, C., Gijsbers, A. C. J., Marcelis, C. L., de Leeuw, N., Veltman, J. A., Brunner, H. G., de Vries, B. B. A. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin. Genet. 79: 296-299, 2011. [PubMed: 21294719, related citations] [Full Text]
Alternative titles; symbols
SNOMEDCT: 1179301003; ORPHA: 268261, 464306, 464311; DO: 0070037;
| Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
|---|---|---|---|---|---|---|
| 21q22.13 | Intellectual developmental disorder, autosomal dominant 7 | 614104 | Autosomal dominant | 3 | DYRK1A | 600855 |
A number sign (#) is used with this entry because of evidence that autosomal dominant intellectual developmental disorder-7 (MRD7) is caused by heterozygous disruption of the DYRK1A gene (600855) on chromosome 21q22.
Van Bon et al. (2011) reported a woman with primary microcephaly (-3 SD), severe mental retardation without speech, anxious autistic behavior, and dysmorphic features, including bitemporal narrowing, deep-set eyes, large simple ears, and a pointed nasal tip. As an infant, she had failure to thrive, abnormal movements, hypoactivity, and febrile seizures. Brain MRI at age 25 showed a mildly atrophic brain without structural abnormalities. Other features included eczema, hypoplasia of breasts, hallux valgus of feet, and an irregular implant of the toes. Van Bon et al. (2011) noted that their patient clearly resembled the 2 patients reported by Moller et al. (2008).
Courcet et al. (2012) reported a 14-year-old girl with severe mental retardation, primary microcephaly (-6 SD), and facial dysmorphic features, including thick lower lip, mild hypotelorism, and hypoplastic earlobes. She had a history of intrauterine growth retardation and feeding difficulties, and developed seizures of multiple types at age 18 months. Other features included severe speech delay, diffuse cortical atrophy on MRI, and hand stereotypies.
Moller et al. (2008) reported 2 unrelated patients with microcephaly, intrauterine growth retardation, postnatal feeding difficulties, and dysmorphic facial features who each had a de novo balanced translocation disrupting the DYRK1A gene: t(9;21)(p12;q22) and t(2;21)(q22;q22), respectively. In the second patient, the 2q22 breakpoint was within intron 39 of the LRP1B (608766) gene. The first child, 24 months old at the time of the report, had large low-set ears, long philtrum, micrognathia, hypogenesis of the corpus callosum, mild developmental delay, and febrile seizures. The second child, age 10 years, had large ears, flat philtrum, asymmetric head, febrile seizures, severe mental retardation, no speech development, and a small ventricular septal defect. Moller et al. (2008) noted the phenotypic similarities to patients with partial monosomy 21 (Matsumoto et al., 1997) and suggested that haploinsufficiency of the DYRK1A gene results in microcephaly as well as other neurodevelopmental anomalies.
In a woman with mental retardation, microcephaly, and dysmorphic features, van Bon et al. (2011) identified a de novo heterozygous deletion in the DYRK1A gene (600855.0001). This patient was identified among a larger group of 3,009 mentally retarded individuals studied for copy number variations in the DYRK1A gene. The report supported a role for DYRK1A in human brain development and showed that haploinsufficiency of DYRK1A can cause a distinctive clinical syndrome with mental retardation, primary microcephaly, intrauterine growth retardation, facial dysmorphism, impaired motor functioning, and behavioral problems.
O'Roak et al. (2012) identified 3 de novo mutations in DYRK1A, 2 frameshift mutations and 1 splice site mutation (600855.0002-600855.0004), among 44 candidate gene sequences in 2,446 autism spectrum disorder probands. The 3 patients with DYRK1A mutations had microcephaly relative to individuals screened without DYRK1A mutations (2-sample permutation test, 2-sided p = 0.0005), and the head sizes of these patients was smaller than those of their parents.
In a 14-year-old girl with severe mental retardation, growth retardation, microcephaly, speech delay, and seizures, Courcet et al. (2012) identified a de novo heterozygous truncating mutation in the DYRK1A gene (600855.0005). This patient was ascertained from a larger cohort of 150 patients with a similar phenotype; she was the only one who had a mutation in the DYRK1A gene.
Courcet, J.-B., Faivre, L., Malzac, P., Masurel-Paulet, A., Lopez, E., Callier, P., Lambert, L., Lemesle, M., Thevenon, J., Gigot, N., Duplomb, L., Ragon, C., Marle, N., Mosca-Boidron, A. L., Huet, F., Philippe, C., Moncla, A., Thauvin-Robinet, C. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy. J. Med. Genet. 49: 731-736, 2012. [PubMed: 23099646] [Full Text: https://doi.org/10.1136/jmedgenet-2012-101251]
Matsumoto, N., Ohashi, H., Tsukahara, M., Kim, K. C., Soeda, E., Niikawa, N. Possible narrowed assignment of the loci of monosomy 21-associated microcephaly and intrauterine growth retardation to a 1.2-Mb segment at 21q22.2. (Letter) Am. J. Hum. Genet. 60: 997-999, 1997. [PubMed: 9106547]
Moller, R. S., Kubart, S., Hoeltzenbein, M., Heye, B., Vogel, I., Hansen, C. P., Menzel, C., Ullmann, R., Tommerup, N., Ropers, H.-H., Tumer, Z., Kalscheuer, V. M. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am. J. Hum. Genet. 82: 1165-1170, 2008. [PubMed: 18405873] [Full Text: https://doi.org/10.1016/j.ajhg.2008.03.001]
O'Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., Munson, J., Hiatt, J. B., and 14 others. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338: 1619-1622, 2012. [PubMed: 23160955] [Full Text: https://doi.org/10.1126/science.1227764]
van Bon, B. W. M., Hoischen, A., Hehir-Kwa, J., de Brouwer, A. P. M., Ruivenkamp, C., Gijsbers, A. C. J., Marcelis, C. L., de Leeuw, N., Veltman, J. A., Brunner, H. G., de Vries, B. B. A. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin. Genet. 79: 296-299, 2011. [PubMed: 21294719] [Full Text: https://doi.org/10.1111/j.1399-0004.2010.01544.x]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM